GlaxoSmithKline (GSK) Tops Q3 EPS by 1c

GlaxoSmithKline (NYSE: GSK) reported Q3 EPS of GBP0.33, GBP0.01 better than the analyst estimate of GBP0.32. Revenue for the quarter came in at GBP7.84 billion versus the consensus estimate of GBP7.86 million.

For earnings history and earnings-related data on GlaxoSmithKline (GSK) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Nike names former Pfizer CFO David Denton as new finance chief
• Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat